Sun Pharma Shares In Focus: US MFN Deal Eases Tariff Risk, Says ICICI Securities — Check Target Price

While Sun Pharma's specialty portfolio is now safeguarded from tariffs, the same safeguard must be extended to Organon post-acquisition, adds the brokerage.